PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators

BACKGROUND The tumor suppressor PTEN regulates many biological processes. A well‐known downstream effector of PTEN is phospho‐Akt. Although PTEN is the most frequently inactivated gene in prostate cancer, its mode of action is not fully understood. We studied the association of regulated PTEN expression with changes in biological function and gene expression profiles. METHODS PTEN‐negative LNCaP cells were stably transfected with wild‐type PTEN cDNA under inducible control, resulting in LNCaP/PTEN cells. Microarray analysis was used to monitor gene expression changes upon induction of PTEN. Expression of selected individual genes was studied in Q‐PCR and siRNA experiments. Cell‐cycle distribution was analyzed by flow cytometry. RESULTS Induced expression of PTEN in LNCaP/PTEN cells significantly inhibited cell proliferation, at least partly due to cell‐cycle arrest at the G1 phase. Expression profiling combined with pathway analysis revealed that PTEN‐dependent G1 growth arrest was associated with an altered mRNA expression of the G1 cell‐cycle regulators Cdc25a, E2F2, cyclin G2, and RBL2/p130. Specific inhibition of Akt signaling by siRNA resulted in downregulation of both E2F2 and Cdc25a mRNA expression and upregulation of the FOXO target cyclin G2, similar to the effect observed by PTEN induction. However, Akt did not mediate the PTEN‐dependent RBL2/p130 mRNA expression in LNCaP/PTEN cells. CONCLUSIONS The results indicate that PTEN dependent gene expression is important in cell‐cycle regulation and is mediated by both Akt‐dependent and ‐independent mechanisms. Prostate 70: 135–146, 2010. ©2009 Wiley‐Liss, Inc.